Related Experiment Videos
Lithium treatment prolongs shock-induced hypoalgesia
N A Teixeira1, D G Pereira, A H Hermini
1Departamento de Farmacologia, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, SP, Brasil.
Summary
Chronic lithium treatment prolongs stress-induced hypoalgesia in rats by affecting the central opioid system. This study reveals lithium
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Stress-induced hypoalgesia is linked to the central opioid system.
- Lithium (Li+) is used in treating bipolar disorder and may influence pain perception.
Purpose of the Study:
- To investigate the effect of chronic lithium treatment on stress-induced hypoalgesia.
- To determine if lithium alters the central opioid system's response to stress.
Main Methods:
- Adult female Wistar rats received lithium chloride or tap water for 28 days.
- Animals were exposed to inescapable footshocks or confinement.
- Pain thresholds were measured using the tail-flick test before and after shock reexposure.
Main Results:
- Inescapable shocks induced hypoalgesia in control and morphine groups.
- Lithium-treated rats exhibited prolonged hypoalgesia for up to three days.
- Shock reexposure reinstated hypoalgesia in controls but not in lithium-treated rats.
Conclusions:
- Chronic lithium treatment prolongs stress-induced hypoalgesia.
- Lithium appears to alter the central opioid system's response to repeated stress exposure.